Therapeutic Areas
Browse Menu
Our therapeutic experience and expertise
- We have vast experience in conducting complex and scientifically challenging First Time in Human (FTIH) studies.
- The majority of our studies involve central nervous system (CNS) indications.
- Our core area of expertise is in Cognitive Disorders and Dementias such as Alzheimer’s Disease, as well as studies in pain.
- We have specialised research facilities for psychedelic testing including fully trained staff and overnight capabilities.
- We have expanded into many other therapeutic areas and can work in any area of research. This includes the complex and evolving area of Oncology, our expertise in this area can be reviewed here.
Cognitive Disorders
Alzheimer’s Disease (mild to severe)
Agitation with Alzheimer’s Disease
Prodromal/Early Onset Dementia
Parkinson’s Disease-Related Cognitive Dysfunction
Mild Cognitive Impairment
Psychiatric Disorders
Major Depressive Disorder
Mixed Depression
Bipolar Disorder
Generalized Anxiety Disorder
Social Anxiety Disorder
Depression with Erectile Dysfunction
Obsessive Compulsive Disorder
Post Traumatic Stress Disorder
Bulimia
Pain
Complex Regional Pain Syndrome
Fibromyalgia
Migraine
Post Traumatic Neuralgia
Post Herpetic Neuralgia
Peripheral Neuropathy
Diabetic Neuropathic Pain
Osteoarthritis of the Knee
Psoriatic Arthropathy
Tennis Elbow
Dermatology
Atopic Dermatitis
Psoriasis
Cardiology
Hypertension
Hyperlipidaemia
Gastrointestinal
IBS
Pouchitis
Ulcerative Colitis
Crohn’s Disease
Metabolic
Diabetes – type 1 and 2
Respiratory
Asthma
COPD
Chronic Refractory Cough
Sleep
Insomnia with Depression
Narcolepsy
Parkinson’s Disease
Mild to Moderate Parkinson’s Disease
Multiple Sclerosis
Spasticity in MS
Women’s Health
Post Menopausal Vasomotor
symptoms (VMS) & Low Bone Mineral
Density (BMD)
Psychedelics
Healthy Volunteers
Treatment-Resistant Depression
Major Depressive Disorder
Opioid Addiction
Post Traumatic Stress Disorder
Rare Diseases
Sickle-Cell Disease (SCD)
Frontotemporal disorders
Oncology
Solid tumours
Haematological malignancies
Anti-cancer therapy induced toxicities